This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Korea Institute of Science and Technology, Txinno Bioscience Inc.. Active years: 2022-2026.
Company Filing History:
1 out of 2,248 
1 out of 1 Years Active: 2022-2026
Title: Jae Eun Cheong: Innovator in Cancer Treatment
Introduction
Jae Eun Cheong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research through his innovative work on protein kinase inhibitors. His research focuses on developing compounds that can effectively combat cancer cell proliferation.
Latest Patents
Jae Eun Cheong holds a patent for "Pyrimido[4,5-d]pyrimidin-2-one derivatives as protein kinase inhibitors." This patent discloses novel pyrimido[4,5-d]pyrimidin-2-one derivative compounds that exhibit excellent anti-proliferative activity against cancer cells. The patent includes details on the preparation of these compounds, their pharmaceutical compositions for preventing and treating cancer metastasis, and their use as active ingredients in anticancer compositions. The compounds demonstrate selective inhibitory activity against LCK and are valuable for inhibiting cancer cells and treating proliferative diseases.
Career Highlights
Jae Eun Cheong is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and has contributed to advancements in the pharmaceutical field.
Collaborations
Some of his notable coworkers include Tae Bo Sim and Seo Jung Han, who collaborate with him on various research projects aimed at enhancing cancer treatment methodologies.
Conclusion
Jae Eun Cheong's innovative research and patent contributions are paving the way for new cancer therapies. His work exemplifies the importance of scientific innovation in the fight against cancer.